Zheng Guodong, Lin Lezhen, Zhong Shusheng, Zhang Qingfeng, Li Dongming
Jiangxi Key Laboratory of Natural Product and Functional Food, College of Food Science and Engineering, Jiangxi Agricultural University, Nanchang, China.
Library of Jiangxi Agricultural University, Nanchang, China.
PLoS One. 2015 Mar 30;10(3):e0122925. doi: 10.1371/journal.pone.0122925. eCollection 2015.
In order to investigate the mechanisms by which puerarin from kudzu root extract regulates lipid metabolism, fifty mice were randomly assigned to five groups: normal diet, high-fat diet (HFD), and HFD containing 0.2%, 0.4% or 0.8% puerarin for 12 weeks. Body weight, intraperitioneal adipose tissue (IPAT) weight, serum biochemical parameters, and hepatic and feces lipids were measured. Activity and mRNA and protein expressions of hepatic lipid metabolism-related enzymes were analyzed. Compared with HFD, 0.4% and 0.8% puerarin significantly decreased body and IPAT weight. There was a significant decrease in the serum and hepatic concentrations of total cholesterol, triglycerides and leptin in mice fed the 0.4% and 0.8% puerarin diets compared with HFD. Fatty acid synthase activity was suppressed in mice fed the 0.4% and 0.8% puerarin diets, while the activities of AMP-activated protein kinase (AMPK), carnitine acyltransferase (CAT) and hormone-sensitive lipase (HSL) were increased. mRNA expression of peroxisome proliferator-activated receptor γ 2 (PPARγ 2) was down-regulated in liver of mice fed the 0.8% diet compared with HFD, while mRNA expression of CAT and HSL was considerably up-regulated by 0.4% and 0.8% puerarin diets. The protein expression of PPARγ2 in liver was decreased and those of p-AMPK, HSL and p-HSL were increased in mice fed 0.4% and 0.8% puerarin diets. These results suggest that > 0.4% puerarin influenced the activity, mRNA and protein levels of hepatic lipid metabolism-related enzymes, decreasing serum and liver lipids, body weight gain and fat accumulation. Puerarin might be beneficial to prevent lifestyle-related diseases.
为了研究葛根提取物中的葛根素调节脂质代谢的机制,将50只小鼠随机分为五组:正常饮食组、高脂饮食组(HFD),以及分别含0.2%、0.4%或0.8%葛根素的高脂饮食组,持续喂养12周。测量体重、腹膜内脂肪组织(IPAT)重量、血清生化参数以及肝脏和粪便中的脂质。分析肝脏脂质代谢相关酶的活性以及mRNA和蛋白质表达。与高脂饮食组相比,0.4%和0.8%的葛根素显著降低了体重和IPAT重量。与高脂饮食组相比,喂食含0.4%和0.8%葛根素饮食的小鼠血清和肝脏中的总胆固醇、甘油三酯和瘦素浓度显著降低。喂食含0.4%和0.8%葛根素饮食的小鼠脂肪酸合酶活性受到抑制,而腺苷酸活化蛋白激酶(AMPK)、肉碱酰基转移酶(CAT)和激素敏感性脂肪酶(HSL)的活性增加。与高脂饮食组相比,喂食含0.8%葛根素饮食的小鼠肝脏中过氧化物酶体增殖物激活受体γ2(PPARγ2)的mRNA表达下调,而0.4%和0.8%葛根素饮食使CAT和HSL的mRNA表达显著上调。喂食含0.4%和0.8%葛根素饮食的小鼠肝脏中PPARγ2的蛋白质表达降低,而p-AMPK、HSL和p-HSL的蛋白质表达增加。这些结果表明,>0.4%的葛根素影响肝脏脂质代谢相关酶的活性、mRNA和蛋白质水平,降低血清和肝脏脂质、体重增加和脂肪堆积。葛根素可能有助于预防与生活方式相关的疾病。